News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
579,965 Results
Type
Article (19042)
Company Profile (166)
Press Release (560756)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (198394)
Career Advice (703)
Deals (30741)
Drug Delivery (86)
Drug Development (65635)
Employer Resources (54)
FDA (12400)
Job Trends (11097)
News (287877)
Policy (24157)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (817)
Accelerated approval (39)
ADA (26)
Adcomms (10)
Allergies (140)
Alliances (41808)
ALS (141)
Alzheimer's disease (1266)
Antibody-drug conjugate (ADC) (344)
Approvals (13011)
Artificial intelligence (502)
ASCO (219)
Autoimmune disease (248)
Automation (40)
Bankruptcy (319)
Best Places to Work (8366)
BIO (47)
BIOSECURE Act (10)
Biosimilars (186)
BioSpace Insights (76)
Biotechnology (103)
Bladder cancer (152)
Brain cancer (55)
Breast cancer (598)
Cancer (4427)
Cardiovascular disease (346)
Career advice (606)
Career pathing (14)
CAR-T (218)
CDC (8)
Celiac Disease (1)
Cell therapy (608)
Cervical cancer (41)
Clinical research (58777)
Collaboration (1695)
Commercialization (3)
Company closure (1)
Compensation (1424)
Complete response letters (61)
COVID-19 (1282)
CRISPR (82)
C-suite (1025)
Cystic fibrosis (123)
Data (6537)
Decentralized trials (1)
Denatured (23)
Depression (125)
Dermatology (67)
Diabetes (437)
Diagnostics (4804)
Digital health (44)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (261)
Drug pricing (126)
Drug shortages (15)
Duchenne muscular dystrophy (227)
Earnings (80829)
Editorial (25)
Employer branding (5)
Employer resources (50)
Events (99125)
Executive appointments (946)
FDA (15499)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (27)
Funding (1203)
Gene editing (163)
Generative AI (35)
Gene therapy (453)
GLP-1 (670)
Government (2007)
Grass and pollen (5)
Guidances (331)
Healthcare (11026)
Hematology (128)
HIV (55)
Huntington's disease (28)
IgA nephropathy (95)
Immunology and inflammation (168)
Immuno-oncology (75)
Indications (192)
Infectious disease (1512)
Inflammatory bowel disease (173)
Inflation Reduction Act (9)
Influenza (96)
Intellectual property (289)
Interviews (93)
IPO (13969)
IRA (33)
Job creations (3104)
Job search strategy (549)
JPM (29)
Kidney cancer (20)
Labor market (39)
Layoffs (251)
Leadership (11)
Legal (6580)
Licensing (3)
Liver cancer (55)
Longevity (21)
Lung cancer (622)
Lymphoma (339)
Machine learning (35)
Management (18)
Manufacturing (887)
Marketing (11)
MASH (162)
Medical affairs (1)
Medical device (9249)
Medtech (9387)
Mergers & acquisitions (17917)
Metabolic disorders (1053)
mRNA (105)
Multiple sclerosis (139)
NASH (15)
Neurodegenerative disease (293)
Neuropsychiatric disorders (69)
Neuroscience (2403)
Neurotech (1)
NextGen: Class of 2026 (3893)
Non-profit (1255)
Now hiring (23)
Obesity (423)
Opinion (158)
Ovarian cancer (174)
Pain (242)
Pancreatic cancer (221)
Parkinson's disease (272)
Partnered (20)
Patents (568)
Patient recruitment (580)
Peanut (39)
People (50595)
Pharmaceutical (45)
Pharmacy benefit managers (23)
Phase 1 (18131)
Phase 2 (25849)
Phase 3 (19167)
Pipeline (8148)
Policy (165)
Postmarket research (2126)
Preclinical (7524)
Press Release (49)
Prostate cancer (233)
Psychedelics (30)
Radiopharmaceuticals (267)
Rare diseases (835)
Real estate (4459)
Recruiting (20)
Regulatory (19655)
Reports (22)
Research institute (955)
Resumes & cover letters (94)
Rett syndrome (40)
RNA editing (12)
RSV (52)
Schizophrenia (145)
Series A (219)
Series B (154)
Service/supplier (4)
Sickle cell disease (97)
Special edition (11)
Spinal muscular atrophy (112)
Sponsored (15)
Startups (2781)
State (2)
Stomach cancer (8)
Supply chain (95)
Tariffs (71)
The Weekly (53)
Vaccines (505)
Venture capital (54)
Weight loss (225)
Women's health (97)
Worklife (4)
Date
Last 7 days (430)
Last 30 days (1415)
Last 365 days (23086)
2026 (13612)
2025 (23301)
2024 (27243)
2023 (31375)
2022 (40746)
2021 (43341)
2020 (39851)
2019 (29679)
2018 (22642)
2017 (24679)
2016 (23524)
2015 (29421)
2014 (25668)
2013 (22071)
2012 (24094)
2011 (24438)
2010 (23670)
Location
Africa (466)
Alabama (80)
Alaska (2)
Arizona (321)
Arkansas (13)
Asia (30114)
Australia (4140)
California (12297)
Canada (3369)
China (1013)
Colorado (494)
Connecticut (452)
Delaware (269)
Europe (54556)
Florida (1878)
Georgia (395)
Hawaii (3)
Idaho (49)
Illinois (842)
India (90)
Indiana (546)
Iowa (14)
Japan (549)
Kansas (117)
Kentucky (36)
Louisiana (29)
Maine (27)
Maryland (1324)
Massachusetts (8470)
Michigan (317)
Minnesota (589)
Mississippi (5)
Missouri (103)
Montana (27)
Nebraska (16)
Nevada (114)
New Hampshire (68)
New Jersey (3113)
New Mexico (18)
New York (3034)
North Carolina (1478)
North Dakota (4)
Northern California (6136)
Ohio (294)
Oklahoma (16)
Oregon (28)
Pennsylvania (2355)
Puerto Rico (26)
Rhode Island (36)
South America (732)
South Carolina (78)
South Dakota (1)
Southern California (5060)
Tennessee (140)
Texas (1965)
United States (41737)
Utah (376)
Vermont (1)
Virginia (257)
Washington D.C. (51)
Washington State (961)
West Virginia (2)
Wisconsin (102)
Wyoming (1)
579,965 Results for "telios pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Telios Pharma Announces Successful Phase 2 Results for TL-925, a Novel Treatment for Dry Eye Disease
Telios Pharma, Inc. today announced topline results from its Phase 2 study assessing TL-925, a first-in-class topical Bruton’s tyrosine kinase (BTK) inhibitor for individuals with moderate to severe dry eye disease (DED).
March 6, 2024
·
4 min read
Press Releases
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 28, 2026
·
5 min read
Press Releases
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
July 15, 2026
·
2 min read
Press Releases
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
July 30, 2026
·
6 min read
Artificial intelligence
Alnylam hops on AI train with up to $2B Inceptive partnership
Alnylam Pharmaceuticals will leverage Inceptive Nucleics’ generative machine learning models to accelerate the development of RNA interference therapies.
June 4, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
May 5, 2026
·
6 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
June 3, 2026
·
5 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
June 3, 2026
·
4 min read
Press Releases
PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
July 29, 2026
·
11 min read
Press Releases
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
June 9, 2026
·
3 min read
1 of 57,997
Next
